NEW YORK, March 20 (GenomeWeb News) - Translational Genomics has begun collecting 1,000 patient samples to undergo screening for variants causing ALS, or Lou Gehrig's Disease, the company said today.
The project is being funded with a donation of $650,000 from Augie's Quest, administered by the Muscular Dystrophy Association, and with a matching investment of $650,000 from TGen, said project director Dietrich Stephen.
Stephen said that the screening will be done on an Affymetrix 500K platform.
The samples are being collected primarily from the University of Pittsburgh, California Pacific Medical Center, Methodist Neorological Institute, and the Western ALS Group.
Stephen said the project will be completed by the end of 2006.